Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: Riluzole in Fragile X Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating riluzole for Fragile X syndrome has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: Indiana University | Conditions: Fragile X Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2017-04-18